Patent intelligence · US
US 6428500
Adhesion prevention and an endoscopic insufflation system therefor
Adhesion prevention and an endoscopic insufflation system therefor
Patent details — US 6428500
- Jurisdiction
- US
- Status
- expired
- Grant date
- Aug 6, 2002
- Expiration
- Aug 1, 2022
- Applicant
- Saturnus AG
- Claims
- 9
- CPC classes
- A61K, A61K31/00, A61K31/137, A61K31/405
Quick answer
US 6428500 (Adhesion prevention and an endoscopic insufflation system therefor) is held by Saturnus AG. Status: expired. Granted Aug 6, 2002. Expires Aug 1, 2022 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Saturnus AG
- Grant date
- Expiration
- Claims
- 9
- CPC classes
- A61K, A61K31/00, A61K31/137, A61K31/405, A61K31/519, A61K31/5575
More from Saturnus AG
Related pharmaceutical patents in our USPTO index.
-
US 12310968
Chiral diaryl macrocycles and uses thereof
granted -
US 12252488
HPK1 antagonists and uses thereof
granted -
US 12215105
HPK1 antagonists and uses thereof
granted -
US 12187739
Diaryl macrocycle polymorph
granted -
US 12071442
Substituted pyrrolo[3,4-c]pyridines as HPK1 antagonists
granted -
US 11981684
Macrocyclic compounds and uses thereof
granted -
US 11926625
HPK1 antagonists and uses thereof
granted -
US 11802292
Modified orthopoxvirus vectors
granted
Related coverage
Frequently asked questions
What is US patent 6428500?
US 6428500 (Adhesion prevention and an endoscopic insufflation system therefor) is held by Saturnus AG. Status: expired. Granted Aug 6, 2002. Expires Aug 1, 2022 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 6428500?
Saturnus AG is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 40 pharmaceutical patents for this assignee.
When does US 6428500 expire?
Our index shows an expiration date of Aug 1, 2022 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.